Global DNA methylation, DNMT1, and MBD2 in patients with rheumatoid arthritis

Immunology Letters

Volumn 135, Issue 1-2, 2011, Pages 96-99

  Liu, Ching Ching ^a   Fang, Tzu Jung ^a,b   Ou, Tsan Teng ^b   Wu, Cheng Chin ^b   Li, Ruei Nian ^c   Lin, Yuan Chao ^a   Lin, Chia Hui ^b   Tsai, Wen Chan ^b   Liu, Hong Wen ^b   Yen, Jeng Hsien ^a,b,c  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

DNMT1; MBD2; Methylation; Rheumatoid arthritis

Indexed keywords

ADALIMUMAB; DNA METHYLTRANSFERASE 1; ETANERCEPT; MESSENGER RNA; METHYL CPG BINDING PROTEIN 2;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DNA METHYLATION; DOWN REGULATION; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; MALE; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; UPREGULATION;

ADULT; ARTHRITIS, RHEUMATOID; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; RNA, MESSENGER;

EID: 78751703609     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2010.10.003     Document Type: Article

References (35)

1. Fax D. Etiology and pathogenesis of rheumatoid arthritis. Arthritis and allied conditions 2005, 1089-1115. Lippincott Williams & Wilkins, Philadelphia. W. Koopman (Ed.).
2. Chen Y.S., Chou P.H., Li S.N., Tsai W.C., Lin K.H., Tsai K.B., et al. Parvovirus B19 infection in patients with rheumatoid arthritis in Taiwan. J Rheumatol 2006, 33:887-891.
3. Yen J.H., Chen J.R., Tsai W.J., Tsai J.J., Liu H.W. HLA-DRB1 genotyping in patients with rheumatoid arthritis in Taiwan. J Rheumatol 1995, 22:1450-1454.
4. Kim J.K., Samaranayake M., Pradhan S. Epigenetic mechanisms in mammals. Cell Mol Life Sci 2009, 66:596-612.
5. Ng H.H., Bird A. DNA methylation and chromatin modification. Curr Opin Genet Dev 1999, 9:158-163.
6. Surani M.A. Imprinting and the initiation of gene silencing in the germ line. Cell 1998, 93:309-312.
7. Nakao M. Epigenetics: interaction of DNA methylation and chromatin. Gene 2001, 278:25-31.
8. Richardson B., Yung R. Role of DNA methylation in the regulation of cell function. J Lab Clin Med 1999, 134:333-340.
9. Detich N., Theberge J., Szyf M. Promoter-specific activation and demethylation by MBD2/demethylase. J Biol Chem 2002, 277:35791-35794.
10. Nishida N., Nagasaka T., Nishimura T., Ikai I., Boland C.R., Goel A. Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma. Hepatology 2008, 47:908-918.
11. Robertson K.D. DNA methylation and human disease. Nat Rev Genet 2005, 6:597-610.
12. Wilson A.S., Power B.E., Molloy P.L. DNA hypomethylation and human diseases. Biochim Biophys Acta 2007, 1775:138-162.
13. Richardson B. DNA methylation and autoimmune disease. Clin Immunol 2003, 109:72-79.
14. Richardson B. Primer: epigenetics of autoimmunity. Nat Clin Pract Rheumatol 2007, 3:521-527.
15. Balada E., Ordi-Ros J., Vilardell-Tarres M. DNA methylation and systemic lupus erythematosus. Ann NY Acad Sci 2007, 1108:127-136.
16. Richardson B., Scheinbart L., Strahler J., Gross L., Hanash S., Johnson M. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 1990, 33:1665-1673.
17. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61:554-558.
18. Jamaluddin M.S., Yang X., Wang H. Hyperhomocysteinemia, DNA methylation and vascular disease. Clin Chem Lab Med 2007, 45:1660-1666.
19. Castro R., Rivera I., Struys E.A., Jansen E.E., Ravasco P., Camilo M.E., et al. Tavares de Almeida I. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin Chem 2003, 49:1292-1296.
20. Cheng X., Blumenthal R.M. Mammalian DNA methyltransferases: a structural perspective. Structure 2008, 16:341-350.
21. Balada E., Ordi-Ros J., Serrano-Acedo S., Martinez-Lostao L., Rosa-Leyva M., Vilardell-Tarres M. Transcript levels of DNA methyltransferases DNMT1, DNMT3A and DNMT3B in CD4+ T cells from patients with systemic lupus erythematosus. Immunology 2008, 124:339-347.
22. Slack A., Cervoni N., Pinard M., Szyf M. Feedback regulation of DNA methyltransferase gene expression by methylation. Eur J Biochem 1999, 264:191-199.
23. Liu CC, Ou TT, Wu CC, Li RN, Lin YC, Lin CH, et al. Global DNA methylation, DNMT1, and MBD2 in patients with systemic lupus erythematosus. Lupus; in press.
24. Fan G., Hutnick L. Methyl-CpG binding proteins in the nervous system. Cell Res 2005, 15:255-261.
25. Klose R.J., Bird A.P. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 2006, 31:89-97.
26. Bhattacharya S.K., Ramchandani S., Cervoni N., Szyf M. A mammalian protein with specific demethylase activity for mCpG DNA. Nature 1999, 397:579-583.
27. Ng H.H., Zhang Y., Hendrich B., Johnson C.A., Turner B.M., Erdjument-Bromage H., et al. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat Genet 1999, 23:58-61.
28. Balada E., Ordi-Ros J., Serrano-Acedo S., Martinez-Lostao L., Vilardell-Tarres M. Transcript overexpression of the MBD2 and MBD4 genes in CD4+ T cells from systemic lupus erythematosus patients. J Leukoc Biol 2007, 81:1609-1616.
29. Creusot F., Acs G., Christman J.K. Inhibition of DNA methyltransferase and induction of Friend erythroleukemia cell differentiation by 5-azacytidine and 5-aza-2'-deoxycytidine. J Biol Chem 1982, 257:2041-2048.
30. Januchowski R., Prokop J., Jagodzinski P.P. Role of epigenetic DNA alterations in the pathogenesis of systemic lupus erythematosus. J Appl Genet 2004, 45:237-248.
31. Deng C., Lu Q., Zhang Z., Rao T., Attwood J., Yung R., et al. Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling. Arthritis Rheum 2003, 48:746-756.
32. Cornacchia E., Golbus J., Maybaum J., Strahler J., Hanash S., Richardson B. Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. J Immunol 1988, 140:2197-2200.
33. Lee B.H., Yegnasubramanian S., Lin X., Nelson W.G. Procainamide is a specific inhibitor of DNA methyltransferase 1. J Biol Chem 2005, 280:40749-40756.
34. Nyce J. Drug-induced DNA hypermethylation and drug resistance in human tumors. Cancer Res 1989, 49:5829-5836.
35. Kim Y.I., Logan J.W., Mason J.B., Roubenoff R. DNA hypomethylation in inflammatory arthritis: reversal with methotrexate. J Lab Clin Med 1996, 128:165-172.